Identification of a Novel Acid Sphingomyelinase Activity Associated with Recombinant Human Acid Ceramidase
Acid ceramidase (AC) is a lysosomal enzyme required to hydrolyze ceramide to sphingosine by the removal of the fatty acid moiety. An inherited deficiency in this activity results in two disorders, Farber Lipogranulomatosis and spinal muscular atrophy with myoclonic epilepsy, leading to the accumulat...
Main Authors: | Xingxuan He, Edward H. Schuchman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/13/11/1623 |
Similar Items
-
Adiponectin overexpression improves metabolic abnormalities caused by acid ceramidase deficiency but does not prolong lifespan in a mouse model of Farber Disease
by: Marie K. Norris, et al.
Published: (2024-06-01) -
Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions
by: Annie Kleynerman, et al.
Published: (2023-02-01) -
The Acid Ceramidase Is a SARS-CoV-2 Host Factor
by: Nina Geiger, et al.
Published: (2022-08-01) -
The steady-state level of plasma membrane ceramide is regulated by neutral sphingomyelinase 2
by: Anne G. Ostermeyer-Fay, et al.
Published: (2025-01-01) -
FARBER DISEASE — DISEASE DESCRIPTION WITH CASE REPORTS
by: I. A. Chikova, et al.
Published: (2014-12-01)